Ossium Health Secures Series C To Expand Bone Marrow Bank, Advance Clinical Trials To Treat Life-Threatening Blood And Immune Diseases
Round Type
Series C
San FranciscoBiotechnologyHealth CareInvestors
Description
Ossium Health, a bioengineering company developing the world's first bank of on-demand bone marrow, today announced a $52 million Series C funding round. The round was led by CPMG, with participation from Vivo Capital, First Round Capital, Manta Ray Ventures, Alumni Ventures, and Asahi Kasei. The company is improving the health, vitality, and longevity of human beings through bioengineering and will deploy this funding to dramatically grow its proprietary bone marrow bank, build on existing clinical trials, and accelerate new product development.
Quick answer
Ossium Health raised an undisclosed amount in a Series C round, dated July 25, 2023. Investors: Asahi Kasei, Alumni Ventures, Manta Ray Ventures, First Round Capital, Vivo Capital and Cpmg. Ossium Health is based in San Francisco, California, United States.
- How much did Ossium Health raise?
- Ossium Health raised an undisclosed amount in a Series C round on July 25, 2023.
- Who invested in Ossium Health?
- Asahi Kasei, Alumni Ventures, Manta Ray Ventures, First Round Capital, Vivo Capital and Cpmg are named as investors in this round.
- What does Ossium Health do?
- Ossium Health is a bioengineering company that leverages its proprietary organ donor bone marrow banking platform to develop stem cell therapies for patients with life-threatening blood and immune diseases.
- Where is Ossium Health based and how big is it?
- Ossium Health is based in San Francisco, California, United States. Fundz records about 91 employees.
- Who are the decision-makers at Ossium Health?
- Fundz holds 1 contact at Ossium Health, including the Executive Officer, Director. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology and Health Care around the same time
Companies in the same sectors as Ossium Health that raised within 45 days of this round, from Fundz verified event records.
- Grit Biotechnology raised $60M (Series B) on September 8, 2023.
- PMGC Holdings Inc. raised $250K (Seed) on September 8, 2023.
- Corteria raised $70M (Funding Round) on September 7, 2023.
- VeinWay raised an undisclosed amount (Series A) on September 7, 2023.
- Nimbus Therapeutics raised $210M (Funding Round) on September 6, 2023.
- Rejuvenation Technologies raised $11M (Seed) on September 6, 2023.
Who to call at Ossium Health, and when
A new round usually means Ossium Health is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Ossium Health raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Ossium Health, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Ossium Health. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Ossium Health raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Ossium Health raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.